Bill Sibold, new Madrigal Pharmaceuticals CEO
September 11, 2023 07:29 AM EDTUpdated 10:54 AM
People

NASH com­pa­ny Madri­gal names for­mer Sanofi ex­ec Bill Si­bold as new CEO

Ayisha Sharma

News Reporter

Madri­gal Phar­ma­ceu­ti­cals has ap­point­ed ex-Sanofi ex­ec­u­tive Bill Si­bold as its new CEO, suc­ceed­ing Paul Fried­man, who will con­tin­ue to serve on the biotech’s board of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times